<!doctype html>
<html>
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width">
<title></title>
<link rel="stylesheet" href="css/style.css">
</head>

<body>

<header>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <p class="title"><a href="index.html">社外秘 研修資料</a></p>
  <div class="r"><a href="039.html"><span>right</span></a></div>
</header>

<div class="wrap">
  <div class="clearfix">
  <img src="img04/multi.png" alt="マルチスタジオ非掲載" width="110" height="20" style="float: right;">
</div>
  <section>
    <p class="pagesubtit"><strong>対オレンシア②セロポジ</strong></p>
    <h1 class="tit">アクテムラは抗CCP抗体±に関わらず有効性を発揮する</h1>
  </section>

  <section>
    <ul class="circle">
    	<li><span>●</span>米Corrona RA registryにて、セロポジとセロネガのRA患者に対してTCZ点滴静注の効果の違いを評価。</li>
    	<li><span>●</span><font color="red">TCZ治療によりセロポジセロネガに関わらず疾患活動性が改善され、両群間で有意差はなかった。</font></li>
    	<li><span>●</span>罹病期間・ベースラインの疾患活動性で調整後も、セロポジ/セロネガ間で違いは見られなかった。</li>
    </ul>
    <div class="table">
      <p class="tit"><strong>抗CCP抗体 陰性/陽性によるアクテムラの臨床効果</strong></p>
      <div class="sc">
        <table class="style1">
          <tr>
            <th rowspan="3"><font size="1">Measure of disease activity</font></th>
            <th colspan="3"><font size="1"><span class="red">CCP Seronegative N=136</span></font></th>
            <th colspan="3"><font size="1"><span class="red">CCP Seropositive, N=180</span></font></th>
            <th rowspan="3" class="lbd_red tbd_red rbd_red"><font size="1">Difference<br/>BetweenGroups<br/>(p-Value)</font></th>
          </tr>
          <tr>
            <th><font size="1">Visit 1</font></th>
            <th><font size="1">Visit 2</font></th>
            <th><font size="1">Visit<br/>Change</font></th>
            <th><font size="1">Visit 1</font></th>
            <th><font size="1">Visit 2</font></th>
            <th><font size="1">Visit<br/>Change</font></th>
          </tr>
          <tr>
            <th><font size="1">Median</font></th>
            <th><font size="1">Median</font></th>
            <th><font size="1">p value<sup>+</sup></font></th>
            <th><font size="1">Median</font></th>
            <th><font size="1">Median</font></th>
            <th><font size="1">p value<sup>+</sup></font></th>
          </tr>
          <tr>
            <td class="left">CDAI</td>
            <td>28.5</td>
            <td>17</td>
            <td>&lt;0.0001</td>
            <td>23.2</td>
            <td>13.7</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.72</td>
          </tr>
          <tr>
            <td class="left">mHAQ N=136; 175</td>
            <td>0.625</td>
            <td>0.625</td>
            <td>0.27</td>
            <td>0.625</td>
            <td>0.5</td>
            <td>0.02</td>
            <td class="lbd_red rbd_red">0.42</td>
          </tr>
          <tr>
            <td class="left">Tender Joint Count (28)</td>
            <td>10</td>
            <td>5</td>
            <td>&lt;0.0001</td>
            <td>7</td>
            <td>3</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.41</td>
          </tr>
          <tr>
            <td class="left">Swollen Joint Count (28)</td>
            <td>5.5</td>
            <td>2</td>
            <td>&lt;0.0001</td>
            <td>6</td>
            <td>3</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.5</td>
          </tr>
          <tr>
            <td class="left">Patient Disease Activity (VAS)</td>
            <td>55</td>
            <td>50</td>
            <td>&lt;0.0001</td>
            <td>55</td>
            <td>45</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.92</td>
          </tr>
          <tr>
            <td class="left">Patient Pain (VAS)</td>
            <td>61.5</td>
            <td>50</td>
            <td>&lt;0.0001</td>
            <td>55</td>
            <td>40</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.94</td>
          </tr>
          <tr>
            <td class="left">Patient fatigue (VAS),<br/>N=128,154</td>
            <td>60</td>
            <td>50</td>
            <td>0.008</td>
            <td>60</td>
            <td>50</td>
            <td>0.005</td>
            <td class="lbd_red rbd_red">0.9</td>
          </tr>
          <tr>
            <td class="left">MD Disease Activity (VAS)</td>
            <td>45</td>
            <td>30</td>
            <td>&lt;0.0001</td>
            <td>40</td>
            <td>21.5</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.57</td>
          </tr>
          <tr>
            <td class="left">ESR N=44,59</td>
            <td>13.5</td>
            <td>2.5</td>
            <td>&lt;0.0001</td>
            <td>28</td>
            <td>10</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red">0.4</td>
          </tr>
          <tr>
            <td class="left">CRP (mg/L) N=50,70</td>
            <td>7.1</td>
            <td>2</td>
            <td>0.0005</td>
            <td>10.8</td>
            <td>2.2</td>
            <td>0.0003</td>
            <td class="lbd_red rbd_red">0.34</td>
          </tr>
          <tr>
            <td class="left">mDAS28 N=136,175</td>
            <td>5.4</td>
            <td>4.5</td>
            <td>&lt;0.0001</td>
            <td>4.9</td>
            <td>4.1</td>
            <td>&lt;0.0001</td>
            <td class="lbd_red rbd_red bbd_red">0.99</td>
          </tr>
        </table>
      </div>
    </div>
    <div class="greenbox">
      <p>
        <strong>アクテムラはオレンシアと異なり、セロポジとセロネガ患者で同じように効果がある事がCorrona registryからも示された</strong>
      </p>
    </div>
    <p class="txt sml right"><a href="http://acrabstracts.org/abstract/clinical-responses-to-tocilizumab-analyzed-by-serologic-status-in-rheumatoid-arthritis/">Laura Cappelli, et al. ACR2016. #1603</a></p>
  </section>
</div>

<footer>
  <div class="l"><a href="javascript:history.back();"><span>left</span></a></div>
  <div class="home"><a href="index.html"><span>HOME</span></a></div>
  <div class="r"><a href="039.html"><span>right</span></a></div>
  <div class="pagetop"><a href="javascript:scroll(0,0);">pagetop</a></div>
</footer>

<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.2/jquery.min.js"></script>
<script src="js/common.js"></script>
</body>
</html>
